Issue 6, 2015
From the journal:

MedChemComm

Synthesis and biological evaluation of potential small moleculeinhibitors of tumor necrosis factor†

Christos Papaneophytou,ab   Polyxeni Alexiou,c   Athanasios Papakyriakou,d   Evangelos Ntougkos,e   Katerina Tsiliouka,f   Anna Maranti,f   Fotini Liepouri,f   Alexandros Strongilos,f   Anthi Mettou,ab   Elias Couladouros,c   Elias Eliopoulos,d   Eleni Douni,de   George Kolliase  and  George Kontopidis*ab  

* Corresponding authors

a Department of Biochemistry, Veterinary School, University of Thessaly, Trikalon 224, Karditsa 43100, Greece
E-mail: gkontopidis@vet.uth.gr
Fax: +30 24410 66041
Tel: +30 24410 66081

b Institute for Research and Technology of Thessaly (I.RE.TE.TH.), The Centre for Research & Technology Hellas (CE.R.TH.), Dimitriados 95 & Paulou Mela, Volos 38333, Greece

c Laboratory of General Chemistry, Department of Science, Agricultural University of Athens, Iera Odos 75, Athens 11855, Greece

d Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Iera Odos 75, Athens 11855, Greece

e Biomedical Sciences Research Center “Alexander Fleming”, Vari, Greece

f pro-ACTINA S.A., Archimidous Str. 59, P.O.Box 205, Koropi, Athens 19400, Greece

Abstract

Inhibition of tumor necrosis factor (TNF) production or function by small molecules has become a major focus in the pharmaceutical industry for the treatment of rheumatoid arthritis. In this study, a series of 39 novel SPD-304 analogs were designed, synthesized and evaluated as TNFinhibitors. Our results show that small structural changes produce ligands with similar binding affinities (Kd) for TNF, but significantly different potencies in a L929 cell-based assay. In addition, contrary to the high affinity of compounds 4e, 8c and 10e for TNF in vitro, the potency of these compounds was determined to be low. We propose that these differences can partly be explained by the physicochemical characteristics of the synthesized SPD-304 analogs. Our findings were supplemented by molecular docking studies on the TNF dimer. These synthesized analogs may serve as a starting point for developing novel TNF inhibitors.

Graphical abstract: Synthesis and biological evaluation of potential small molecule inhibitors of tumor necrosis factor

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C5MD00023H
Article type
Concise Article
Submitted
18 Jan 2015
Accepted
18 May 2015
First published
19 May 2015

Med. Chem. Commun., 2015,6, 1196-1209

Author version available

Download author version (PDF)

Permissions

Request permissions

Synthesis and biological evaluation of potential small moleculeinhibitors of tumor necrosis factor

C. Papaneophytou, P. Alexiou, A. Papakyriakou, E. Ntougkos, K. Tsiliouka, A. Maranti, F. Liepouri, A. Strongilos, A. Mettou, E. Couladouros, E. Eliopoulos, E. Douni, G. Kollias and G. Kontopidis, Med. Chem. Commun., 2015, 6, 1196 DOI: 10.1039/C5MD00023H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements